60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
Q4 2025 vs. Q3 2025
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 7 | 7 | 0 |
| Shares | 42.6K | 44.4K | +1.76K (+4.1%) |
| Value | $62.9K | $22.5K | −$40.4K (−64.2%) |
New holders (2)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 22,051 | $11.2K | 0.00% |
| Barclays PLC | 1,513 | $769 | 0.00% |
Sold out (2)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 25,211 | $37.3K |
| Citigroup Inc | 189 | $278 |